Veregen ( DrugBank: - )

1 disease

ID	Disease name (Link within this page)	Number of trials
160	Congenital ichthyosis	2

160. Congenital ichthyosis

Clinical trials : 42 / Drugs : 71 - (DrugBank : 21) / Drug target genes : 18 - Drug target pathways : 112

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01222000 (ClinicalTrials.gov)	October 2010	12/10/2010	Treatment of the Recessive Nonbullous Congenital Ichthyosis by the Epigallocatechine Cutaneous	TREATMENT OF THE RECESSIVE NONBULLOUS CONGENITAL ICHTHYOSIS BY THE EPIGALLOCATECHINE CUTANEOUS	Lamellar Ichthyosis	Drug: apply VEREGEN ® 10 % on a randomized area and the moisturizing cream of the other side	Centre Hospitalier Universitaire de Nice	NULL	Not yet recruiting	8 Years	N/A	Both	8	Phase 3	France
2	EUCTR2009-013656-77-FR (EUCTR)	15/10/2009	06/08/2009	Traitment of recessive nonbullous congenital ichthyosis with topic Epigallocatechin.	Traitment of recessive nonbullous congenital ichthyosis with topic Epigallocatechin.	Recessive nonbullous congenital ichthyosis MedDRA version: 12.0;Level: HLT;Classification code 10021 ...	Trade Name: VEREGEN(R) Product Name: VEREGEN(R)	Nice University Hospital	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	0		France

First Previous1Next Last